Related references
Note: Only part of the references are listed.Performance comparison of blood collection tubes as liquid biopsy storage system for minimizing cfDNA contamination from genomic DNA
Yunlong Zhao et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2019)
Guidelines for the Preanalytical Conditions for Analyzing Circulating Cell-Free DNA
Romain Meddeb et al.
CLINICAL CHEMISTRY (2019)
Evaluation of Storage Tubes for Combined Analysis of Circulating Nucleic Acids in Liquid Biopsies
Aoife Ward Gahlawat et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Functions and clinical implications of exosomes in pancreatic cancer
Ling Qian et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer
Vincent Bernard et al.
GASTROENTEROLOGY (2019)
Emerging Evidence for the Clinical Relevance of Pancreatic Cancer Exosomes
Roxanne L. Massoumi et al.
PANCREAS (2019)
Ultrasensitive and quantitative detection of EGFR mutations in plasma samples from patients with non-small-cell lung cancer using a dual PNA clamping-mediated LNA-PNA PCR clamp
Shichao Zhang et al.
ANALYST (2019)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Targeted deep sequencing of circulating tumor DNA in metastatic pancreatic cancer
Andreas W. Berger et al.
ONCOTARGET (2018)
Amplicon-based next-generation sequencing of plasma cell-free DNA for detection of driver and resistance mutations in advanced non-small cell lung cancer
N. Guibert et al.
ANNALS OF ONCOLOGY (2018)
Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer
Colin M. Court et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer
O. Nordgard et al.
BRITISH JOURNAL OF SURGERY (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients
Oliver A. Zill et al.
CLINICAL CANCER RESEARCH (2018)
Improved Risk Stratification by Circulating Tumor Cell Counts in Pancreatic Cancer
Katharina E. Effenberger et al.
CLINICAL CANCER RESEARCH (2018)
In Situ Detection and Quantification of AR-V7, AR-FL, PSA, and KRAS Point Mutations in Circulating Tumor Cells
Amin El-Heliebi et al.
CLINICAL CHEMISTRY (2018)
Prognostic Implications of Multiplex Detection of KRAS Mutations in Cell-Free DNA from Patients with Pancreatic Ductal Adenocarcinoma
Min Kyeong Kim et al.
CLINICAL CHEMISTRY (2018)
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
Jason D. Merker et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies
Lena Gorgannezhad et al.
LAB ON A CHIP (2018)
Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications
Jiangdong Qiu et al.
MOLECULAR CANCER (2018)
Mutant KRAS Circulating Tumor DNA Is an Accurate Tool for Pancreatic Cancer Monitoring
Ruth Perets et al.
ONCOLOGIST (2018)
Cancer detection: Seeking signals in blood
Mark Kalinich et al.
SCIENCE (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
Evaluation of pre-analytical factors affecting plasma DNA analysis
Havel Markus et al.
SCIENTIFIC REPORTS (2018)
Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients
Bente Risberg et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2018)
Evaluation of commercial kits for purification of circulating free DNA
Russell J. Diefenbach et al.
CANCER GENETICS (2018)
Investigation of appropriate pre-analytical procedure for circulating free DNA from liquid biopsy
Akemi Sato et al.
Oncotarget (2018)
Factors that influence quality and yield of circulating-free DNA: A systematic review of the methodology literature
R. M. Trigg et al.
HELIYON (2018)
Biomarker-Based Therapy in Pancreatic Ductal Adenocarcinoma: An Emerging Reality?
Benjamin A. Krantz et al.
CLINICAL CANCER RESEARCH (2018)
Circulating Tumor Cells Expressing Markers of Tumor-Initiating Cells Predict Poor Survival and Cancer Recurrence in Patients with Pancreatic Ductal Adenocarcinoma
Katherine E. Poruk et al.
CLINICAL CANCER RESEARCH (2017)
Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker
Daniel Pietrasz et al.
CLINICAL CANCER RESEARCH (2017)
The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA
Sonya Parpart-Li et al.
CLINICAL CANCER RESEARCH (2017)
A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative
Michael J. Pishvaian et al.
ONCOTARGET (2017)
Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients
He Cheng et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Comparison of Blood Collection Tubes from Three Different Manufacturers for the Collection of Cell-Free DNA for Liquid Biopsy Mutation Testing
Christina Alidousty et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
Evaluation of Streck BCT and PAXgene Stabilised Blood Collection Tubes for Cell-Free Circulating DNA Studies in Plasma
Kristina Warton et al.
MOLECULAR DIAGNOSIS & THERAPY (2017)
Application of circulating tumor DNA in prospective clinical oncology trials - standardization of preanalytical conditions
Lisanne F. van Dessel et al.
MOLECULAR ONCOLOGY (2017)
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
Sushrut Kamerkar et al.
NATURE (2017)
Simple multiplexed PCR-based barcoding of DNA for ultrasensitive mutation detection by next-generation sequencing
Anders Stahlberg et al.
NATURE PROTOCOLS (2017)
Integrating liquid biopsies into the management of cancer
Giulia Siravegna et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
Joshua D. Cohen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer
Patricia Adamo et al.
ONCOTARGET (2017)
Circulating and disseminated tumor cells in pancreatic cancer and their role in patient prognosis: a systematic review and meta-analysis
David Stephenson et al.
ONCOTARGET (2017)
Isolation of circulating tumor cells from pancreatic cancer by automated filtration
Nora Brychta et al.
ONCOTARGET (2017)
Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): Identification of prognostic subtypes
Anna Melissa Schlitter et al.
SCIENTIFIC REPORTS (2017)
Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring
Yi Chang et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2017)
KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 Mutations in Pancreatic Cancer
Jonas Cicenas et al.
CANCERS (2017)
Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer
Marzia Del Re et al.
SCIENTIFIC REPORTS (2017)
Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for Tand N Staging in Patients With Pancreatic Adenocarcinoma
Peter J. Allen et al.
ANNALS OF SURGERY (2017)
Clinical value of ctDNA in upper-GI cancers: A systematic review and meta-analysis
A. Creemers et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2017)
Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours
David Sefrioui et al.
BRITISH JOURNAL OF CANCER (2017)
The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis
Lei Xu et al.
CLINICAL CANCER RESEARCH (2017)
Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis
Sivesh K. Kamarajah et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
Nicholas McGranahan et al.
CELL (2017)
Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer
Kjersti Tjensvoll et al.
MOLECULAR ONCOLOGY (2016)
Ultra-fast, label-free isolation of circulating tumor cells from blood using spiral microfluidics
Majid Ebrahimi Warkiani et al.
NATURE PROTOCOLS (2016)
KRAS mutations in pancreatic circulating tumor cells: a pilot study
Birte Kulemann et al.
TUMOR BIOLOGY (2016)
Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma
Katherine E. Poruk et al.
ANNALS OF SURGERY (2016)
Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer
Naoto Hadano et al.
BRITISH JOURNAL OF CANCER (2016)
An improved CTC isolation scheme for pairing with downstream genomics: Demonstrating clinical utility in metastatic prostate, lung and pancreatic cancer
Gayatri Premasekharan et al.
CANCER LETTERS (2016)
Detection of KRAS Mutations in Circulating Tumor DNA by Digital PCR in Early Stages of Pancreatic Cancer
Nora Brychta et al.
CLINICAL CHEMISTRY (2016)
Clinical Significance of Circulating Tumor Microemboli as a Prognostic Marker in Patients with Pancreatic Ductal Adenocarcinoma
Ming-Chu Chang et al.
CLINICAL CHEMISTRY (2016)
Analysis of Base-Position Error Rate of Next-Generation Sequencing to Detect Tumor Mutations in Circulating DNA
Nicolas Pecuchet et al.
CLINICAL CHEMISTRY (2016)
The Cobas (R) EGFR Mutation Test v2 assay
Paul Brown
FUTURE ONCOLOGY (2016)
Detection of Hot-Spot Mutations in Circulating Cell-Free DNA From Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas
Andreas W. Berger et al.
GASTROENTEROLOGY (2016)
Genetics and biology of pancreatic ductal adenocarcinoma
Haoqiang Ying et al.
GENES & DEVELOPMENT (2016)
Quantitative analysis of the BRAF V600E mutation in circulating tumor-derived DNA in melanoma patients using competitive allele-specific TaqMan PCR
Atsuko Ashida et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2016)
Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization
Yang Gao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
A High Circulating Tumor Cell Count in Portal Vein Predicts Liver Metastasis From Periampullary or Pancreatic Cancer A High Portal Venous CTC Count Predicts Liver Metastases
Yu Wen Tien et al.
MEDICINE (2016)
Development of a Novel c-MET-Based CTC Detection Platform
Tian Zhang et al.
MOLECULAR CANCER RESEARCH (2016)
Functional studies on circulating and disseminated-tumor cells in carcinoma patients
Catherine Alix-Panabieres et al.
MOLECULAR ONCOLOGY (2016)
Circulating tumor cell technologies
Meghaan M. Ferreira et al.
MOLECULAR ONCOLOGY (2016)
Integrated digital error suppression for improved detection of circulating tumor DNA
Aaron M. Newman et al.
NATURE BIOTECHNOLOGY (2016)
Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma
Efrat Dotan et al.
PANCREAS (2016)
Genetic variations associated with gemcitabine treatment outcome in pancreatic cancer
Liang Li et al.
PHARMACOGENETICS AND GENOMICS (2016)
Detection of circulating tumor cells in patients with esophagogastric or pancreatic adenocarcinoma using the CellSearch® system: An observational feasibility study
Tobias Piegeler et al.
ONCOLOGY LETTERS (2016)
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
Catherine Alix-Panabieres et al.
CANCER DISCOVERY (2016)
Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer
Feifei Cheng et al.
ONCOTARGET (2016)
Combining radiomic features with a miRNA classifier may improve prediction of malignant pathology for pancreatic intraductal papillary mucinous neoplasms
Jennifer B. Permuth et al.
ONCOTARGET (2016)
Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer
Evelyn Kidess-Sigal et al.
ONCOTARGET (2016)
Drug resistance in cancer: molecular evolution and compensatory proliferation
Ran Friedman
ONCOTARGET (2016)
Quantitative imaging to evaluate malignant potential of IPMNs
Alexander N. Hanania et al.
ONCOTARGET (2016)
Fragment Length of Circulating Tumor DNA
Hunter R. Underhill et al.
PLOS GENETICS (2016)
Cancer of the Pancreas: Molecular Pathways and Current Advancement in Treatment
Kishore Polireddy et al.
JOURNAL OF CANCER (2016)
Diagnostic potency of EUS-guided FNA for the evaluation of pancreatic mass lesions
Amir Houshang Mohammad Alizadeh et al.
ENDOSCOPIC ULTRASOUND (2016)
Pancreatic cancer
Jorg Kleeff et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Development of an Automated and Sensitive Microfluidic Device for Capturing and Characterizing Circulating Tumor Cells (CTCs) from Clinical Blood Samples
Priya Gogoi et al.
PLOS ONE (2016)
Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing
Inga Medina Diaz et al.
PLOS ONE (2016)
Cell-free circulating tumor DNA in cancer
Zhen Qin et al.
CHINESE JOURNAL OF CANCER (2016)
Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer
Julie Earl et al.
BMC CANCER (2015)
Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer
Hideaki Kinugasa et al.
CANCER (2015)
High Levels of Cell-Free Circulating Nucleic Acids in Pancreatic Cancer are Associated With Vascular Encasement, Metastasis and Poor Survival
Nidhi Singh et al.
CANCER INVESTIGATION (2015)
Cell-free DNA: Preanalytical variables
Abel Jacobus Bronkhorst et al.
CLINICA CHIMICA ACTA (2015)
Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR
Anna L. Reid et al.
CLINICAL BIOCHEMISTRY (2015)
Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility
Michail Ignatiadis et al.
CLINICAL CANCER RESEARCH (2015)
Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound
Daniel V. T. Catenacci et al.
GASTROENTEROLOGY (2015)
Genetic analysis of circulating tumor cells in pancreatic cancer patients: A pilot study
Karin Goerner et al.
GENOMICS (2015)
Vascular Resection in Pancreatic Cancer
Ruzica Rosalia Luketina et al.
INDIAN JOURNAL OF SURGERY (2015)
Novel approaches in the management of pancreatic ductal adenocarcinoma: potential promises for the future
Gaurav Goel et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
Circulating Epithelial Cells in Patients with Pancreatic Lesions: Clinical and Pathologic Findings
Christy E. Cauley et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2015)
Circulating tumor cell detection using a parallel flow micro-aperture chip system
Chun-Li Chang et al.
LAB ON A CHIP (2015)
A Combinatory Strategy for Detection of Live CTCs Using Microfiltration and a New Telomerase-Selective Adenovirus
Yanchun Ma et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Circulating Tumor Cells Found in Patients With Localized and Advanced Pancreatic Cancer
Birte Kulemann et al.
PANCREAS (2015)
Circulating tumor-derived DNA is shorter than somatic DNA in plasma
Florent Mouliere et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Comparison of droplet digital PCR and conventional quantitative PCR for measuring EGFR gene mutation
Bo Zhang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients
Mark Sausen et al.
NATURE COMMUNICATIONS (2015)
Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas
Oliver A. Zill et al.
CANCER DISCOVERY (2015)
Circulating Tumor DNA as a Liquid Biopsy for Cancer
Ellen Heitzer et al.
CLINICAL CHEMISTRY (2015)
Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer
Yujuan Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Involvement of epithelial to mesenchymal transition in the development of pancreatic ductal adenocarcinoma
Kennichi Satoh et al.
JOURNAL OF GASTROENTEROLOGY (2015)
SELEX Aptamer Used as a Probe to Detect Circulating Tumor Cells in Peripheral Blood of Pancreatic Cancer Patients
Jinqiang Zhang et al.
PLOS ONE (2015)
Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation
Lei Xu et al.
PLOS ONE (2015)
Portal vein-circulating tumor cells predict liver metastases in patients with resectable pancreatic cancer
Massimiliano Bissolati et al.
TUMOR BIOLOGY (2015)
Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer
Erina Takai et al.
SCIENTIFIC REPORTS (2015)
Co-amplification at Lower Denaturation-temperature PCR Combined with Unlabled-probe High-resolution Melting to Detect KRAS Codon 12 and 13 Mutations in Plasma-circulating DNA of Pancreatic Adenocarcinoma Cases
Jiong Wu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer
F. Rothe et al.
ANNALS OF ONCOLOGY (2014)
Flexible Micro Spring Array Device for High-Throughput Enrichment of Viable Circulating Tumor Cells
Ramdane A. Harouaka et al.
CLINICAL CHEMISTRY (2014)
Detection of Circulating Pancreas Epithelial Cells in Patients With Pancreatic Cystic Lesions
Andrew D. Rhim et al.
GASTROENTEROLOGY (2014)
Liquid Biopsies: Genotyping Circulating Tumor DNA
Luis A. Diaz et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Size-selective collection of circulating tumor cells using Vortex technology
Elodie Sollier et al.
LAB ON A CHIP (2014)
Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip
Weian Sheng et al.
LAB ON A CHIP (2014)
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Aaron M. Newman et al.
NATURE MEDICINE (2014)
Microfluidic, marker-free isolation of circulating tumor cells from blood samples
Nezihi Murat Karabacak et al.
NATURE PROTOCOLS (2014)
Molecular analysis of circulating tumour cells-biology and biomarkers
Matthew G. Krebs et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
The Notch Pathway Is Important in Maintaining the Cancer Stem Cell Population in Pancreatic Cancer
Ethan V. Abel et al.
PLOS ONE (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Circulating tumor cells in pancreatic cancer patients: Enrichment and cultivation
Vladimir Bobek et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Circulating tumor cells as a prognostic factor in patients with small cell lung cancer
Satoshi Igawa et al.
ONCOLOGY LETTERS (2014)
Single-Cell RNA Sequencing Identifies Extracellular Matrix Gene Expression by Pancreatic Circulating Tumor Cells
David T. Ting et al.
CELL REPORTS (2014)
Usefulness of Circulating Tumor Cell Detection in Pancreatic Adenocarcinoma Diagnosis
Isabelle Iwanicki-Caron et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
New Generation of Ensemble-Decision Aliquot Ranking Based on Simplified Microfluidic Components for Large-Capacity Trapping of Circulating Tumor Cells
Mengxia Zhao et al.
ANALYTICAL CHEMISTRY (2013)
Modular Microsystem for the Isolation, Enumeration, and Phenotyping of Circulating Tumor Cells in Patients with Pancreatic Cancer
J. W. Kamande et al.
ANALYTICAL CHEMISTRY (2013)
Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial
F. C. Bidard et al.
ANNALS OF ONCOLOGY (2013)
Circulating plasma DNA and DNA integrity in breast cancer patients undergoing neoadjuvant chemotherapy
Julia Lehner et al.
CLINICA CHIMICA ACTA (2013)
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah-Jane Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Circulating tumor cells versus tumor-derived cell-free DNA: rivals or partners in cancer care in the era of single-cell analysis?
Evelyn Kidess et al.
GENOME MEDICINE (2013)
BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles
Walter W. Chen et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
The Pitfalls of CA19-9 Routine Testing and Comparison of Two Automated Immunoassays in a Reference Oncology Center
Rita Passerini et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker
L. Khoja et al.
BRITISH JOURNAL OF CANCER (2012)
EMT and Dissemination Precede Pancreatic Tumor Formation
Andrew D. Rhim et al.
CELL (2012)
A Genome-Wide Association Study of Overall Survival in Pancreatic Cancer Patients Treated with Gemcitabine in CALGB 80303
Federico Innocenti et al.
CLINICAL CANCER RESEARCH (2012)
An Epigenetic Approach to Pancreatic Cancer Treatment: The Prospective Role of Histone Deacetylase Inhibitors
Nicola Tinari et al.
CURRENT CANCER DRUG TARGETS (2012)
Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination
Michael Millward et al.
INVESTIGATIONAL NEW DRUGS (2012)
Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers
Dena Marrinucci et al.
PHYSICAL BIOLOGY (2012)
Multimarker Gene Analysis of Circulating Tumor Cells in Pancreatic Cancer Patients: A Feasibility Study
Andreia de Albuquerque et al.
ONCOLOGY (2012)
Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
Tim Forshew et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing
Rebecca J. Leary et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
A novel Phase I/IIa design for early phase oncology studies and its application in the evaluation of MK-0752 in pancreatic cancer
John Whitehead et al.
STATISTICS IN MEDICINE (2012)
A Central Role for RAF→MEK→ERK Signaling in the Genesis of Pancreatic Ductal Adenocarcinoma
Eric A. Collisson et al.
CANCER DISCOVERY (2012)
High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number
Benjamin J. Hindson et al.
ANALYTICAL CHEMISTRY (2011)
Detection of apoptotic circulating tumor cells in advanced pancreatic cancer following 5-fluorouracil chemotherapy
Chuanli Ren et al.
CANCER BIOLOGY & THERAPY (2011)
Multiplex Amplification Coupled with COLD-PCR and High Resolution Melting Enables Identification of Low-Abundance Mutations in Cancer Samples with Low DNA Content
Coren A. Milbury et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2011)
Marker Expression in Circulating Cancer Cells of Pancreatic Cancer Patients
Jiahua Zhou et al.
JOURNAL OF SURGICAL RESEARCH (2011)
Detection and quantification of rare mutations with massively parallel sequencing
Isaac Kinde et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Perspective on Cancer Cell Metastasis
Christine L. Chaffer et al.
SCIENCE (2011)
A Colorimetric Method for Detection of K-ras Codon 12 Point Mutations in DNA Extracted from Tissue and Peripheral Blood in Pancreatic Disorders
Robert A. Ollar et al.
BIOCHEMICAL GENETICS (2010)
Differential Methylation of Cell-Free Circulating DNA Among Patients With Pancreatic Cancer Versus Chronic Pancreatitis
Thomas Liggett et al.
CANCER (2010)
K-ras mutational status predicts poor prognosis in unresectable pancreatic cancer
H. Chen et al.
EJSO (2010)
Characterization of Circulating Tumor Cells by Fluorescence In Situ Hybridization
Joost F. Swennenhuis et al.
CYTOMETRY PART A (2009)
Methylation Profile of Circulating Plasma DNA in Patients With Pancreatic Cancer
Anatoliy A. Melnikov et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
Follow-Up Study of K-ras Mutations in the Plasma of Patients With Pancreatic Cancer Correlation With Clinical Features and Carbohydrate Antigen 19-9
Jan Daebritz et al.
PANCREAS (2009)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result
Toshio Kurihara et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY (2008)
Circulating tumor cells (CTC) detection: Clinical impact and future directions
Patrizia Paterlini-Brechot et al.
CANCER LETTERS (2007)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Malcolm J. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Aptamer-conjugated nanoparticles for the collection and detection of multiple cancer cells
Joshua E. Smith et al.
ANALYTICAL CHEMISTRY (2007)
Identification of pancreatic cancer stem cells
Chenwei Li et al.
CANCER RESEARCH (2007)
K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients - In relation to cigarette smoking
Li Jiao et al.
PANCREAS (2007)
Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter study
D. A. Richards et al.
ANNALS OF ONCOLOGY (2006)
Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer
E Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Detection of K-ras mutations in the plasma DNA of pancreatic cancer patients
T Uemura et al.
JOURNAL OF GASTROENTEROLOGY (2004)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
Phase III double-blind placebo-controlled study of farnesyl transferase inhibitor R115777 in patients with refractory advanced colorectal cancer
S Rao et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations
D Dressman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Quantification of free circulating DNA as a diagnostic marker in lung cancer
G Sozzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
A prospective study of detection of pancreatic carcinoma by combined plasma K-ras mutations and serum CA19-9 analysis
DX Feng et al.
PANCREAS (2002)
The usefulness of serial changes in serum CA19-9 levels in the diagnosis of pancreatic cancer
N Tanaka et al.
PANCREAS (2000)
Share Paper
